Taheebo Tea & Pau d’Arco Research

A common question people ask is whether Pau d'Arco is safe for daily use. Some older reports suggested that high doses of lapachol could be toxic. However, a human safety study published in 2023 provided much-needed clarity.

Researchers administered 1,050 mg per day of encapsulated Pau d'Arco to a group of women for eight weeks to observe its effects on primary dysmenorrhea, or painful periods. The results were encouraging. The participants showed a significant reduction in pain. More importantly, the researchers tracked laboratory markers for the full 8 weeks and found no adverse toxic effects.

This 2023 human study is an important safety reference. It suggests that a daily dose of about 1 gram was well tolerated in that trial while also helping with inflammatory pain symptoms. If you want to review the paper directly, you can read it here: 2023 Human Safety Study, PMC10032363. When you drink Taheebo tea, you are consuming these compounds in a natural, aqueous form. This makes it a practical option for long-term wellness support. You can read more about how people use our tea on our testimonials page.

One of the most exciting areas of research involves the compound beta-lapachone. In 2024 and 2025, scientists focused on a specific enzyme called NQO1. This enzyme is often overexpressed in cancer cells, including lung, pancreatic, breast, and cervical tumors.

Beta-lapachone acts like a biochemical trap inside cells with high NQO1 activity. When this compound enters that environment, the cell rapidly processes it. This reaction generates a burst of reactive oxygen species, or ROS. The cell then burns through energy and reducing power trying to contain the damage. Eventually, it triggers programmed cell death.

That mechanism matters because it helps explain why researchers keep studying Pau d'Arco compounds in oncology. A 2025 cervical cancer paper in Frontiers in Pharmacology examined this NQO1 pathway directly. If you want to read the paper, see 2025 Cervical Cancer and NQO1 Study, Frontiers in Pharmacology.

This section also needs the earlier animal data for context. In a 2008 mouse study, tumor-bearing models given Pau d'Arco-related treatment showed longer survival and signs of immune recovery compared with untreated controls. In a 2016 colorectal cancer study, researchers reported reduced spread to the lungs and increased apoptosis, which is programmed cancer cell death. Normal, healthy cells usually express much lower levels of NQO1, so you can see why this pathway keeps getting attention in cancer research.

Read our full guide on Pau d'Arco and Cancer Research

Most people know Pau d'Arco as a "tea to kill candida." This is its most famous use in the wellness world. Standard Candida albicans is usually no match for the naphthaquinones in the bark. However, a new threat has emerged: Candida auris. This is a multi-drug resistant fungus that has hospitals on high alert.

Research from 2025 has investigated lapachol complexes against Candida auris. This matters because C. auris is known for multidrug resistance and hospital outbreaks. In the 2025 JBTH paper, researchers evaluated lapachol-based compounds against this fungus. If you want the direct source, read 2025 Candida auris and Lapachol Study, JBTH. The findings support the idea that compounds from Pau d'Arco deserve more study for fungal defense.

Research over the years has also reported activity against a broader list of microbes. Commonly cited targets include:

1. Candida species.
2. Aspergillus species.
3. Staphylococcus species.
4. Streptococcus species.
5. Helicobacter pylori.
6. Viruses including Herpes I, Herpes II, influenza, and polio.

That broad target list helps explain why this bark has stayed relevant in both folk medicine and modern lab research. Different papers use different extracts, doses, and test models, so results are not all equal. Still, the pattern is consistent enough to justify ongoing interest.

If you are fighting a stubborn fungal overgrowth, consistency is the key. Many of our customers share their success stories on the Candida testimonials page. We have also heard long-term wellness stories from customers such as Robin Hadel, who shared a survival journey that spans decades. Personal stories are not clinical proof, but they do show why many families continue to keep this tea in their routine for the long haul. The science confirms that the tea provides a broad-spectrum antifungal defense that modern medicine is still trying to replicate.

You cannot get these results from a low-quality tea bag. The research is clear: the active compounds are in the inner bark (the phloem). Many companies sell "Pau d'Arco" that includes the outer bark or the heartwood. These parts of the tree contain very little lapachol.

At Taheebo Wellness Tea, we only use the premium inner bark. We also provide specific instructions because these compounds are not easily extracted in cold water. You must boil the bark to break down the tough plant fibers and release the medicine.

For the best results, follow our brewing instructions. We recommend using a fine grind for a more concentrated extract. This ensures you get the full profile of naphthaquinones and antioxidants discussed in the research.

The science of Pau d'Arco is no longer a mystery. From the NQO1 mechanism in cancer research to digestive support and NAD+ recycling, the data gives you a clearer picture of how this bark works. This tea contains natural compounds that researchers continue to study for immune and gut support.

Whether you are looking for a tea to kill candida or a natural way to boost your energy, Taheebo tea offers a proven path. We invite you to experience these benefits for yourself.

Please share this article with anyone who you feel may benefit from this research.